ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023
Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer.
Hari S Iyer, Kevin H Kensler, Jane B Vaselkiv, Konrad H Stopsack, Charlotte Roscoe, Elisa V Bandera, Bo Qin, Thomas L Jang, Tamara L Lotan, Peter James and 4 more
Open access · greenAbstract read
In one paragraphArticle in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 5 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors at 5 institutions in 1 country.
Hari S IyerSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0002-7596-9049 Kevin H KenslerDepartment of Population Health Sciences, Weill Cornell Medicine, New York, New York.ORCID 0000-0001-7515-7270 Jane B VaselkivDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-7702-9504 Konrad H StopsackDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-0722-1311 Charlotte RoscoeDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-9169-6458 Elisa V BanderaSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0002-8789-2755 Bo QinSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0003-2110-6050 Thomas L JangUrologic Oncology Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.ORCID 0000-0001-5886-3835 Tamara L LotanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0002-0494-9067 Peter JamesDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-2858-1973 Jaime E HartDepartment of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-0826-1163 Lorelei A MucciDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2551-4927 Francine LadenDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2813-2174 Timothy R RebbeckDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-4799-1900 Harvard University · USRutgers, The State University of New Jersey · USBrigham and Women's Hospital · USCornell University · USJohns Hopkins University · US
Funding
VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6MTranslational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6MTranslational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI JAIME ELIZABETH HART · 1985 to 2026
$44.6MTumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI KANTOFF, PHILIP W · 2002 to 2017
$36.2MTraining Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3MCancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0MTraining Program in Environmental EpidemiologyT32ES007069 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LADEN, FRANCINE · 1985 to 2024
$13.9MBuilt Environment Assessment through Computer visiON (BEACON): Applying Deep Learning to Street-Level and Satellite Images to Estimate Built Environment Effects on Cardiovascular HealthR01HL150119 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JAMES, PETER · 2020 to 2024
$3.9MRelationship Between Multiple Environmental Exposures and CVD Incidence and Survival: Vulnerability and SusceptibilityR01ES028033 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DOMINICI, FRANCESCA, LADEN, FRANCINE · 2018 to 2022
$3.5MThe effects of environmental exposures on semen quality and the sperm epigenomeR01ES028712 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI HART, JAIME ELIZABETH · 2018 to 2022
$3.3MPrecision Interception of Aggressive Prostate Cancer in African American MenP20CA233255 · NCI · DANA-FARBER CANCER INST · PI REBBECK, TIMOTHY R · 2018 to 2020
$3.2MContributions of tumor molecular subtypes to prostate cancer racial disparitiesR00CA245900 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KENSLER, KEVIN HUGHES · 2021 to 2023
$689kNCI NIH HHS P20 CA233255NCI NIH HHS P30 CA006516NCI NIH HHS P30 CA006973NCI NIH HHS P50 CA090381NCI NIH HHS R00 CA245900NCI NIH HHS T32 CA009001NCI NIH HHS U01 CA167552NHLBI NIH HHS R01 HL150119NIEHS NIH HHS P30 ES000002NIEHS NIH HHS R01 ES028033NIEHS NIH HHS R01 ES028712NIEHS NIH HHS T32 ES007069
6 · The paper itselfAbstract
backgroundThere is growing evidence that unfavorable neighborhood contexts may influence prostate cancer progression. Whether these associations may be explained in part by differences in tumor-level somatic alterations remain unclear.
methodsData on tumor markers (PTEN, p53, ERG, and SPINK1) were obtained from 1,157 participants with prostate cancer in the Health Professionals Follow-up Study. Neighborhood greenness, socioeconomic status, and the income Index of Concentration at Extremes were obtained from satellite and census data and linked to participants' address at diagnosis and at study enrollment. Exposures were scaled to an interquartile range and modeled as tertiles. Bivariate associations between tertiles of neighborhood factors and tumor markers were assessed in covariate adjusted logistic regression models to estimate ORs and 95% confidence intervals.
resultsThere was no association between any of the neighborhood contextual factors and PTEN, p53, ERG, or SPINK1 in bivariate or multivariable adjusted models. Results were generally consistent when modeling exposure using exposure at diagnosis or at study enrollment.
conclusionsIn this multilevel study of men with prostate cancer, we found no evidence of associations between neighborhood context and tumor tissue markers. IMPACT: Our results provide some of the first empirical data in support of the hypothesis that prostate cancer risk conferred by tumor tissue markers may arise independently of underlying neighborhood context. Prospective studies in more diverse populations are needed to confirm these findings.
Indexed as
Prostatic NeoplasmsTrypsin Inhibitor, Kazal PancreaticBiomarkers, TumorFollow-Up StudiesHumansMalePrognosisProspective StudiesResidence CharacteristicsTranscriptional Regulator ERGTumor Suppressor Protein p53Biomarkers, TumorSPINK1 protein, humanTranscriptional Regulator ERGTrypsin Inhibitor, Kazal PancreaticTumor Suppressor Protein p53
Identifiers
PMID37249585
PMCPMC10527012
OpenAlexW4378746373
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390